Trials / Completed
CompletedNCT05196997
The De-Morton Mobility Index Turkish Version in Intensive Care Patients
Construct Validity and Test-Retest Reliability of The De-Morton Mobility Index Turkish Version in Intensive Care Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- Izmir Katip Celebi University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
De Morton Mobility Index is recommended for the evaluation of mobility in the evidence-based guidelines, in patients in intensive care units. The aim of our study is to examine the validity and reliability of the Turkish version of the De Morton Mobility Index in patients hospitalized in the respiratory intensive care unit.
Detailed description
De Morton Mobility Index is recommended for the evaluation of mobility in the evidence-based guidelines, in patients in intensive care units. The aim of our study is to examine the validity and reliability of the Turkish version of the De Morton Mobility Index in patients hospitalized in the respiratory intensive care unit. Patients aged 18 years and over who were discharged from the ICU were included in our study. We used De-Morton Mobility Index, Bartel Index, Katz Activities of Daily Living Rating Scale and MRC Muscle Strength Test for convergent validity. De-Morton Mobility assessment for test-retest reliability was performed again on the 1st day of the patient's service.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Mobility and Functional Assessments | The first evaluation was made on the day the patient was discharged from the intensive care unit. DEMMI, Bartel Index, Katz Activities of Daily Living Rating Scale and MRC Muscle Strength Test were performed to the patient, respectively. De-Morton Mobility assessment for test-retest reliability was performed again on the 1st day of the patient's service. |
Timeline
- Start date
- 2018-04-01
- Primary completion
- 2019-02-20
- Completion
- 2019-02-20
- First posted
- 2022-01-19
- Last updated
- 2022-01-19
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05196997. Inclusion in this directory is not an endorsement.